⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

October 5, 2026Archives of Pediatrics and Adolescent Medicine

Metabolic and Bariatric Surgery and GLP-1 Receptor Agonist Use Among Adolescents

John B. Rode Thomas H. Inge Allan D. Wu Caren Mangarelli Justin R. Ryder

View Full Paper

Ask AI

Bookmark

Share

Abstract

This cross-sectional study assesses quarterly trends in glucagon-like peptide-1 receptor agonist prescribing and metabolic and bariatric surgery use among adolescents eligible for metabolic and bariatric surgery.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Rode et al. (2026) studied this question.

synapsesocial.com/papers/6ac5e0ebb2dceb1c429fb70f https://doi.org/10.1001/jamapediatrics.2026.4584

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1GLP-1 Receptor Agonist and Bariatric Surgery Utilization Among Adolescents and Young AdultsCross-Sectional Study · 2026 · 1 citations
2Trends in Metabolic and Bariatric Surgery Use During the GLP-1 Receptor Agonist EraCross-Sectional Study · 2026 · 11 citations
3GLP-1 Receptor Agonist Prescriptions for Adolescents With Obesity and Associated DisparitiesOriginal Research · 2026 · 3 citations
4Biliary Events and GLP-1 Receptor Agonist Therapy in Adolescents and Young AdultsCohort Study · 2026
5Trends in Metabolic Bariatric Surgery Utilization in the Era of GLP-1s, 2022-2024Original Research · 2026